Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.

Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Abstract Text:

    imran hassanImran Hassan,y nancy youY Nancy You,roman shyyanRoman Shyyan,eric j dozoisEric J Dozois,thomas c smyrkThomas C Smyrk,scott h okunoScott H Okuno,cathy d schleckCathy D Schleck,david o hodgeDavid O Hodge,john h donohueJohn H Donohue,imran hassanImran Hassan,y nancy youY Nancy You,roman shyyanRoman Shyyan,eric j dozoisEric J Dozois,thomas c smyrkThomas C Smyrk,scott h okunoScott H Okuno,cathy d schleckCathy D Schleck,david o hodgeDavid O Hodge,john h donohueJohn H Donohue,imran hassanImran Hassan,y nancy youY Nancy You,roman shyyanRoman Shyyan,eric j dozoisEric J Dozois,thomas c smyrkThomas C Smyrk,scott h okunoScott H Okuno,cathy d schleckCathy D Schleck,david o hodgeDavid O Hodge,john h donohueJohn H Donohue,

    BACKGROUND: Tyrosine kinase inhibitors have been shown to have marked clinical efficacy in patients with unresectable or metastatic gastrointestinal stromal tumors (GIST). We performed a comparative and prognostic analysis of our experience with surgically managed GIST to determine factors associated with adverse oncologic outcomes. METHODS: Oncologic outcomes of 191 patients with primary GIST surgically managed between 1978 and 2004 at a single institution were reviewed. Prognostic factors were analyzed by Cox analysis (hazard ratio [HR] and 95% confidence interval [95% CI]) and included age, sex, disease presentation (asymptomatic vs. symptomatic), tumor site (stomach, small bowel, colorectal), disease extent (localized vs. metastatic) and risk levels (high, intermediate, low, very-low) assigned on the basis of size and number of mitoses according to current National Institutes of Health recommendations. Primary end points were disease-free survival (DFS) and disease-specific survival (DSS). RESULTS: A total of 186 patients (97%) had c-kit-positive GIST. There were 54% high, 22% intermediate, 18% low, and 8% very low risk GIST originating from the stomach (54%), small bowel (36%), and colon and rectum (10%). Median patient age was 65 (range, 13-91) years, and 108 subjects (57%) were male. Seventy-two percent of patients had symptomatic local disease, and 21% patients had synchronous metastases. Most (95%) underwent R0 resections of their primary tumor. Among 146 patients (76%) with localized disease at presentation undergoing R0 resection, the 5-year DFS was 65%. High-risk GIST (HR 12, 95% CI, 5-32, P < .0001), symptomatic presentation (HR 2.5, 95% CI, 1.1-6, P = .04), and GIST in the small bowel (HR 2.8, 95% CI, 1-5, P = .003) were independently associated with decreased DFS. After a median follow-up of 63 months among survivors, the 5-year DSS was 68%. High-risk disease (HR 14.3, 95% CI, 5-41, P < .0001), symptomatic presentation (HR 3.1, 95% CI, 1.2-7.9, P = .02), and GIST in the small bowel (2.6,3 95% CI, 1-5, P = .006) were independently associated with decreased DSS. CONCLUSIONS: High-risk GIST are associated with increased disease recurrence and decreased survival despite complete surgical resection. These patients should receive adjuvant therapy in the form of tyrosine kinase inhibitors.

    Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Publishing Authors By Initials

    i hassanI Hassan,yn youYN You,r shyyanR Shyyan,ej dozoisEJ Dozois,tc smyrkTC Smyrk,sh okunoSH Okuno,cd schleckCD Schleck,do hodgeDO Hodge,jh donohueJH Donohue,i hassanI Hassan,yn youYN You,r shyyanR Shyyan,ej dozoisEJ Dozois,tc smyrkTC Smyrk,sh okunoSH Okuno,cd schleckCD Schleck,do hodgeDO Hodge,jh donohueJH Donohue,i hassanI Hassan,yn youYN You,r shyyanR Shyyan,ej dozoisEJ Dozois,tc smyrkTC Smyrk,sh okunoSH Okuno,cd schleckCD Schleck,do hodgeDO Hodge,jh donohueJH Donohue,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Annals of surgical oncology

    VOLUME: 15

    Page Numbers: 52-9

    Journal Abbreviation: Ann. Surg. Oncol.

    ISSN: 1534-4681

    DAY: 14

    MONTH: 11

    YEAR: 2007

    Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9420840

    Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.

    AFFILIATION: Division of Colon and Rectal Surgery, SIU School of Medicine, 701 N Rutledge, PO Box 19638, Springfield, IL, 67308, USA, ihassan@siumed.edu.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Ann Surg Oncol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News